 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Chevallard Daniel R.
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-07-25 Purchase | 2017-07-25 6:07 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 54,945 | $0.91 | $50,000 | 59,415 (Direct) | View |
| 2019-04-01 Sale | 2019-04-03 4:16 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 3,253 | $0.9814 | $3,192 | 9,372 (Direct) | View |
| 2019-05-14 Sale | 2019-05-16 5:21 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 10,000 | $1.4089 | $14,089 | 80,539 (Direct) | View |
| 2019-07-01 Sale | 2019-07-02 5:41 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 2,669 | $1.3115 | $3,500 | 77,870 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-05-10 Option Award | 2017-05-12 4:48 pm | N/A 2027-05-09 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2018-01-05 Option Award | 2018-01-05 6:55 pm | N/A 2028-01-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 350,000 | $0 | 350,000 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 4:37 pm | N/A 2028-05-16 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 250,000 | $0 | 250,000 (Direct) | View |
| 2019-02-05 Option Award | 2019-02-06 4:50 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 30,000 | $0.95 | 34,578 (Direct) | View |
| 2019-02-05 Option Award | 2019-02-06 4:50 pm | N/A 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 30,000 | $0 | 30,000 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:21 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 55,414 | $0 | 90,539 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:21 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 8,000 | $0 | 7,500 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:57 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 8,000 | $0 | 8,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:00 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 78,912 | $0 | 78,912 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 5:49 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 12,000 | $0.9 | 56,760 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 5:49 pm | N/A 2029-07-30 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 12,000 | $0 | 98,817 (Direct) | View |